Phibro Animal Health Corporation (PAHC)
USD 17.88
(-4.18%)
USD 17.88
(-4.18%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 265.91 Million USD | -4.2% |
| 2023 | 277.57 Million USD | 7.1% |
| 2022 | 259.15 Million USD | 19.81% |
| 2021 | 216.31 Million USD | 9.99% |
| 2020 | 196.65 Million USD | -0.84% |
| 2019 | 198.32 Million USD | 11.31% |
| 2018 | 178.17 Million USD | 10.5% |
| 2017 | 161.23 Million USD | -3.85% |
| 2016 | 167.69 Million USD | 11.95% |
| 2015 | 149.78 Million USD | 4.61% |
| 2014 | 143.18 Million USD | 2.25% |
| 2013 | 140.03 Million USD | 16.57% |
| 2012 | 120.12 Million USD | 0.0% |
| 2007 | 89.4 Million USD | -7.64% |
| 2006 | 96.8 Million USD | 0.21% |
| 2005 | 96.6 Million USD | 22.9% |
| 2004 | 78.6 Million USD | -10.48% |
| 2003 | 87.8 Million USD | 2.81% |
| 2002 | 85.4 Million USD | 1.91% |
| 2001 | 83.8 Million USD | 66.27% |
| 2000 | 50.4 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 286.68 Million USD | 2.7% |
| 2024 FY | 265.91 Million USD | -4.2% |
| 2024 Q3 | 282.28 Million USD | -1.53% |
| 2024 Q4 | 265.91 Million USD | -5.8% |
| 2024 Q1 | 279.15 Million USD | 0.57% |
| 2023 Q3 | 292.83 Million USD | 1.33% |
| 2023 Q1 | 280.84 Million USD | 8.37% |
| 2023 FY | 277.57 Million USD | 7.1% |
| 2023 Q4 | 277.57 Million USD | -5.21% |
| 2023 Q2 | 288.98 Million USD | 2.9% |
| 2022 FY | 259.15 Million USD | 19.81% |
| 2022 Q3 | 249.91 Million USD | 8.29% |
| 2022 Q4 | 259.15 Million USD | 3.7% |
| 2022 Q1 | 221.31 Million USD | 2.31% |
| 2022 Q2 | 230.78 Million USD | 4.28% |
| 2021 Q3 | 206.25 Million USD | -3.32% |
| 2021 Q4 | 216.31 Million USD | 4.87% |
| 2021 Q2 | 213.33 Million USD | 3.64% |
| 2021 FY | 216.31 Million USD | 9.99% |
| 2021 Q1 | 205.84 Million USD | 4.67% |
| 2020 FY | 196.65 Million USD | -0.84% |
| 2020 Q1 | 203.87 Million USD | 2.8% |
| 2020 Q3 | 177.28 Million USD | -8.38% |
| 2020 Q4 | 196.65 Million USD | 10.93% |
| 2020 Q2 | 193.5 Million USD | -5.08% |
| 2019 Q2 | 193.09 Million USD | 3.93% |
| 2019 Q3 | 189.87 Million USD | -1.67% |
| 2019 Q4 | 198.32 Million USD | 4.45% |
| 2019 FY | 198.32 Million USD | 11.31% |
| 2019 Q1 | 185.79 Million USD | 4.28% |
| 2018 Q1 | 170.92 Million USD | 6.01% |
| 2018 Q3 | 184.47 Million USD | 6.26% |
| 2018 Q4 | 178.17 Million USD | -3.42% |
| 2018 FY | 178.17 Million USD | 10.5% |
| 2018 Q2 | 173.61 Million USD | 1.57% |
| 2017 Q3 | 163.83 Million USD | 3.16% |
| 2017 Q4 | 161.23 Million USD | -1.59% |
| 2017 FY | 161.23 Million USD | -3.85% |
| 2017 Q1 | 162.64 Million USD | -3.01% |
| 2017 Q2 | 158.81 Million USD | -2.35% |
| 2016 Q4 | 167.69 Million USD | -0.36% |
| 2016 Q3 | 168.29 Million USD | 8.98% |
| 2016 Q1 | 147.29 Million USD | -1.66% |
| 2016 Q2 | 154.42 Million USD | 4.84% |
| 2016 FY | 167.69 Million USD | 11.95% |
| 2015 Q3 | 136.36 Million USD | -5.86% |
| 2015 FY | 149.78 Million USD | 4.61% |
| 2015 Q4 | 149.78 Million USD | 9.84% |
| 2015 Q2 | 144.85 Million USD | -1.04% |
| 2015 Q1 | 146.38 Million USD | 2.23% |
| 2014 Q4 | 143.18 Million USD | 0.27% |
| 2014 Q1 | 141.4 Million USD | 0.98% |
| 2014 FY | 143.18 Million USD | 2.25% |
| 2014 Q2 | 140.44 Million USD | -0.68% |
| 2014 Q3 | 142.8 Million USD | 1.68% |
| 2013 Q4 | 140.03 Million USD | 0.0% |
| 2013 FY | 140.03 Million USD | 16.57% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | 120.12 Million USD | 0.0% |
| 2007 FY | 89.4 Million USD | -7.64% |
| 2006 Q3 | 93.9 Million USD | -0.95% |
| 2006 FY | 96.8 Million USD | 0.21% |
| 2006 Q1 | 99.3 Million USD | 2.8% |
| 2006 Q2 | 94.8 Million USD | -4.53% |
| 2005 Q2 | 97.6 Million USD | 12.06% |
| 2005 Q1 | 87.1 Million USD | 10.81% |
| 2005 FY | 96.6 Million USD | 22.9% |
| 2005 Q4 | 96.6 Million USD | -2.52% |
| 2005 Q3 | 99.1 Million USD | 1.54% |
| 2004 Q1 | 94.4 Million USD | 7.52% |
| 2004 Q4 | 78.6 Million USD | -11.09% |
| 2004 Q3 | 88.4 Million USD | 0.57% |
| 2004 FY | 78.6 Million USD | -10.48% |
| 2004 Q2 | 87.9 Million USD | -6.89% |
| 2003 Q2 | 98 Million USD | 8.89% |
| 2003 Q1 | 90 Million USD | 0.0% |
| 2003 FY | 87.8 Million USD | 2.81% |
| 2003 Q4 | 87.8 Million USD | -5.89% |
| 2003 Q3 | 93.3 Million USD | -4.8% |
| 2002 FY | 85.4 Million USD | 1.91% |
| 2001 FY | 83.8 Million USD | 66.27% |
| 2000 FY | 50.4 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Journey Medical Corporation | 10.2 Million USD | -2505.438% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | -139.137% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -3828.365% |
| Pacira BioSciences, Inc. | 104.35 Million USD | -154.819% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -4536.833% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -4536.833% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Safety Shot Inc | 1.86 Million USD | -14122.524% |
| Alpha Teknova, Inc. | 11.59 Million USD | -2193.523% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | -722.439% |
| Bright Green Corporation | - USD | -Infinity% |
| Dynavax Technologies Corporation | 53.29 Million USD | -398.989% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | -305.21% |
| Cosmos Health Inc. | 4.78 Million USD | -5452.474% |
| PainReform Ltd. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -32738.37% |
| Embecta Corp. | 152.1 Million USD | -74.826% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | -2183.086% |
| Procaps Group, S.A. | 96.83 Million USD | -174.608% |
| Theratechnologies Inc. | 6.06 Million USD | -4283.63% |
| Harrow Health, Inc. | 10.86 Million USD | -2346.959% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -9679.735% |
| Biofrontera Inc. | 10.9 Million USD | -2337.761% |
| DURECT Corporation | 2.21 Million USD | -11883.371% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | -243.519% |
| Cronos Group Inc. | 30.33 Million USD | -776.467% |
| OptiNose, Inc. | 8.05 Million USD | -3202.422% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -26591099900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -4565.897% |
| Organogenesis Holdings Inc. | 28.25 Million USD | -841.178% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -9832.756% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -5668.933% |
| Radius Health, Inc. | 278.64 Million USD | 4.569% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -7853.63% |
| ProPhase Labs, Inc. | 3.84 Million USD | -6822.963% |
| Procaps Group S.A. | 96.83 Million USD | -174.608% |
| Alvotech | 74.43 Million USD | -257.249% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 92.336% |
| Rockwell Medical, Inc. | 5.87 Million USD | -4429.228% |
| Aytu BioPharma, Inc. | 12.63 Million USD | -2004.892% |
| SIGA Technologies, Inc. | 64.21 Million USD | -314.073% |
| Tilray Brands, Inc. | 252.08 Million USD | -5.484% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | -565.127% |
| Shineco, Inc. | 1.58 Million USD | -16639.491% |
| PetIQ, Inc. | 159.3 Million USD | -66.915% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 174150.583% |
| Incannex Healthcare Limited | -10.01 Million USD | 2755.127% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | -594.285% |
| Alimera Sciences, Inc. | 1.87 Million USD | -14051.73% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | -605.596% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -16412.201% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -5831.541% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -104444.49% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | -2461.763% |
| Hempacco Co., Inc. | 2.54 Million USD | -10358.117% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | -257.249% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | -456.369% |
| Lantheus Holdings, Inc. | 64.02 Million USD | -315.298% |
| Currenc Group, Inc. | 732.91 Thousand USD | -36181.486% |
| Kamada Ltd. | 87.74 Million USD | -203.044% |
| Indivior PLC | 141.79 Million USD | -87.526% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -55086.576% |
| Flora Growth Corp. | 8.5 Million USD | -3025.423% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -104444.49% |
| Evolus, Inc. | 10.99 Million USD | -2317.812% |
| HUTCHMED (China) Limited | 50.25 Million USD | -429.092% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | -151.255% |
| Akanda Corp. | 1.28 Million USD | -20563.007% |